Exergame and Robotic Therapy Impact on Tenascin-C and Functional Outcome on Stroke Patients

Comparison of Tenascin-C Value Rates and Functional Outcomes Between Exergame Therapy and Robotic Therapy in Post-Stroke Patients

This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are:

1, Effectiveness of interventions in functional outcome recovery across time 2. Effectiveness of interventions in affecting Tenascin-C level 3. Clinical outcome difference between all interventions

Participants will be allocated into three groups, either a robotic group, exergame group as the main interventions, and standard rehabilitation group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome

Study Overview

• Status: Recruiting
• Conditions: Stroke; Paralysis Arm
• Intervention / Treatment: Procedure: Conventional; Procedure: Exergame; Procedure: Robotic

Detailed Description

1, Research design This research is an experimental study with a randomized controlled trial research design.

2. Study Setting The research will be carried out among post-stroke patients at two teaching hospitals and one physical rehabilitation center in Makassar

3. Procedure

a. Standard Rehabilitation Comprehensive medical management and rehabilitation of disabilities caused by stroke through the neurorehabilitation approach with the aim of optimizing recovery and or modifying existing remaining symptoms so that stroke people are able to carry out functional activities independently, can adapt to the environment and achieve quality life

b. Exergame Physical exercise of the entire body carried out through active video games that require gross motor skills, visual-spatial coordination, balance, and energy expenditure that are proportional to the intensity of moderate physical activity

c. Robotic Therapy Mirror therapy intervention uses the help of robot exoskeletal to move the sick side. A set of mirror therapy exercises, using Syrebo robotics, using 1 set of Activity Daily Living (ADL) training during therapy, and using a mirror that will reflect a healthy side shadow.

4. Time frame the procedure will be conducted in parallel three times per week for a total of six weeks, with two measurements before and after six weeks of training

5. Outcomes

1. motoric ability of upper extremity using Fugl-Meyer Assessment for Upper Extremities (FMA-UE)
2. Dexterity, coordination and response of finger using the Nine Hole Peg Test (NHPT)
3. Hand motor strength with Handgrip dynamometer

4. Level of Tenascin-C in blood serum before and after

   6. Case definition

a. type of stroke determined by radiology imaging b. phase of stroke (acute, sub-acute or chronic) c. cognitive ability measured using mini-mental state examination (MMSE) d. Spasticity measured by the Modified Ashworth Scale (MAS)

7. Procedure

a. The data collected is primary data obtained in accordance with the inclusion criteria.

b. Samples who are willing to become research subjects will undergo interviews, physical examinations, FMA-UE-Hand Motor Domain, handgrip and NHPT examinations. The interview questionnaire in this study will contain a list of patient identities including name, age, marital status, address, educational history, employment history, history of stroke, cognitive examination (MMSE), and self-reported visual ability.

8. Measurement tools

1. The FMA-UE-Hand Motor Domain scoring system is used to evaluate upper extremity motor function in patients with neurological disorders, such as stroke. The scoring system ranges from 0-14, with higher scores indicating better motor function. The FMA-UE-Hand Motor domain assessment system is broken down into several subscales, namely Mass Flexion and Extension movements, followed by functional movements of grasping (Grasp), including Hook Grasp, Thumb Adduction, Pincer Grasp, Cylinder Grasp, and Spherical Grasp. The assessment will get a score of 0 = None or no movement, 1 = Partial or limited movement, and 2 = Full or perfect movement.
2. The NHPT assessment consists of a square board with 9 pegs. At one end of the board, there is a hole for the peg, and at the other end, there is a shallow round plate for holding the peg. NHPT is performed by having the patient take pegs from a container, one at a time, and place them into the holes in a board, as quickly as possible. The patient must then remove the pegs from the holes, one at a time, and reinsert them into the housing. To practice and register initial scores, the test must be started with the unaffected upper limb. The board should be placed in the centre of the patient's body with the housing holding the pegs oriented toward the hand being tested. Only the hand being evaluated should perform the test. The non-evaluated hand is allowed to grip the edge of the board to provide stability. Patients are scored based on the time required to complete the test activity, recorded in seconds. The stopwatch must start from the moment the participant touches the first peg until the last peg touches the container. This assessment requires a board, of wood or plastic, with 9 holes (10 mm diameter, 15 mm depth), spaced 32 mm or 50 mm apart and a stopwatch.

3. Tenascin-C To perform an ELISA for Tenascin-C, the procedure involves preparing samples and standards according to the kit instructions. The samples and standards are added to wells pre-coated with Tenascin-C-specific antibodies and incubated to facilitate binding. Following incubation, the wells are washed to remove any unbound substances. A detection antibody, conjugated with an enzyme, is then added and incubated. After additional washing, a substrate solution is introduced, causing a color change proportional to the amount of Tenascin-C present. The reaction is stopped with an acid solution, and the optical density is measured using a plate reader. The Tenascin-C concentration in the samples is determined by comparing the optical density readings to a standard curve. Typically, Tenascin-C levels are reported in pg/mL, and the assay range and sensitivity depend on the specific kit used. Accurate interpretation requires comparing the sample values to the standard curve to assess Tenascin-C expression levels, which can provide insights into the biological or pathological state being investigated.

   9. Sample Size

   This clinical trial aims to compare the effectiveness of Robotic Therapy, Exergame Therapy, and Standard Therapy in improving hand function among post-stroke patients. Assuming a standard deviation of 26.75, an expected mean difference of 18.72, and a dropout rate of 30%, the sample size is calculated to be 16 participants per group. This calculation is based on a 95% confidence level (Zα = 1.96) and 80% power (Zβ = 0.84) across the three arms.

   10. Proposed Statistical Analysis

   the data will be analyzed using Analysis of Variance/ ANOVA assuming no difference in baseline characteristic. Next, the relationship between continuous values will be assessed using the Pearson correlation test (normally distributed data) or the Spearman test (data not normally distributed) to determine how big the correlation is between these variables.

• Study Type: Interventional
• Enrollment (Estimated): 48
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Auliyah Fadly, MD; Phone Number: +6281234328649; Email: muh.auliyah.fadly@gmail.com

Study Locations

• Indonesia
  • South Sulawesi
    • Makassar, South Sulawesi, Indonesia, 90245
      • Recruiting
      • Hasanuddin University, Faculty of Medicine
      • Principal Investigator: Yose Waluyo, MD, PhD
      • Principal Investigator: Husnul Mubarak, MD, PhD
      • Principal Investigator: Nuralam Sam, MD, PhD
      • Contact: Auliyah Fadly, MD; Phone Number: +62411591331; Email: muh.auliyah.fadly@gmail.com
      • Principal Investigator: Rumaisah Hasan, MD
    • Makassar, South Sulawesi, Indonesia, 90245
      • Recruiting
      • Wahidin Sudirohusodo General Hospital
      • Principal Investigator: Yose Waluyo, MD, PhD
      • Principal Investigator: Nuralam Sam, MD. PhD
      • Principal Investigator: Husnul Mubarak, MD
      • Principal Investigator: Rumaisah Hasan, MD
      • Contact: Auliyah Fadly; Phone Number: +62 411 583333; Email: muh.auliyah.fadly@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Patients after ischemic or hemorrhagic stroke
• stable hemodynamics and neurologic state.
• Patients have never undergone treatment with any intervention
• Able to watch television with or without glasses from a distance of 1 meter.
• Patients can understand informed consent to participate in research

Exclusion Criteria:

• Patients with a history of seizures or epilepsy.
• Patients with severe cognitive disorders that can interfere with research objectives (MMSE score <24).
• Patients with field deficits or severe vision disorders.
• The patient is unable to sit upright without help.
• Patients with significant pain in the affected upper limb.
• Patients with significant sensory decreases in the upper limb that are affected
• Patients with other medical conditions (musculoskeletal, neuromuscular, cardio respiration) are uncontrolled and are at risk of disrupting the ability to exercise.

Dropout Criteria

• Patients who were declared dead
• Refusing to continue the training session or less < 50% of all sessions.
• Experiencing hemodynamic and neurological disorders during the training program process.
• Experiencing cybersickness twice in successive training sessions

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Standard Rehabilitation/Conventional; The conventional exercise therapy group will be given diathermic, electricity modality, hydrotherapy, and therapeutic exercises in the form of muscle stretching, strengthening exercises, transfer exercises, walking exercises, and hand function exercises for 3 times a week within 6 weeks.	Procedure: Conventional; Hand Training with Physical Therapist
Experimental: Exergame; Conventional therapy coupled with virtual reality Exergame exercises on the hands for 3 times a week a time 6 weeks	Procedure: Exergame; Hand Training assisted with Virtual-Reality
Experimental: Robotic; conventional therapy coupled with robotic therapy exercises on the hands for 3 times a week a time of 6 weeks	Procedure: Robotic; Hand Training assisted with Robotic Syrebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fugl-Meyer Assessment Upper Extremity (FMA-EU) Score	a motoric assessment with each score range from 0-2 with a total score range from 0-66. Higher score indicates better and free movement	changes of FMA-UE score from pre-intervention to six weeks after intervention
Nine Hole Peg Test Value	an assessment for finger dexterity and coordination where the time of the subject to accomplish task will be recorded. Average healthy adult male completed the NHPT in 19.0 seconds (SD 3.2) with the right hand, and in 20.6 seconds (SD 3.9) with the left hand. For healthy adult women, the NHPT was completed in 17.9 seconds (SD 2.8) and 19.6 seconds (SD 3.4) with the right and left hands, respectively.	changes of NHPT values from pre-intervention to six weeks after intervention
Handgrip Dynamometer value	The handgrip dynamometer measures hand strength, with a typical range of 0 to 100 kg (0 to 220 lb). For men, normal handgrip strength usually falls between 30-60 kg (66-132 lb), while for women it ranges from 20-40 kg (44-88 lb).	changes of handgrip values from pre-intervention to six weeks after intervention
Tenascin-C value	The normal range of Tenascin-C levels in healthy individuals typically falls between 50 to 200 ng/mL.	changes of Tenascin-C value from pre-intervention to six weeks after intervention

Collaborators and Investigators

• Sponsor: Hasanuddin University
• Investigators: Principal Investigator: Rumaisah Hasan, MD, Hasanuddin University

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2023
• Primary Completion (Estimated): December 1, 2024
• Study Completion (Estimated): March 1, 2025

Study Registration Dates

• First Submitted: August 17, 2024
• First Submitted That Met QC Criteria: August 17, 2024
• First Posted (Actual): August 20, 2024

Study Record Updates

• Last Update Posted (Actual): August 20, 2024
• Last Update Submitted That Met QC Criteria: August 17, 2024
• Last Verified: August 1, 2024

More Information

Terms related to this study

• Keywords: Functional Outcome; Robotic Rehabilitation; Tenascin-C; Post-Stroke; Video-assisted Rehabilitation
• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Stroke; Paralysis
• Other Study ID Numbers: 0208242322

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: No To protect the confidentiality, should the data need to share, any de-identified data will be shared for peer-review

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No